Benoît Brethon

4.6k total citations · 1 hit paper
54 papers, 1.3k citations indexed

About

Benoît Brethon is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Hematology. According to data from OpenAlex, Benoît Brethon has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 20 papers in Oncology and 19 papers in Hematology. Recurrent topics in Benoît Brethon's work include Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (15 papers) and CAR-T cell therapy research (11 papers). Benoît Brethon is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (15 papers) and CAR-T cell therapy research (11 papers). Benoît Brethon collaborates with scholars based in France, Germany and Italy. Benoît Brethon's co-authors include André Baruchel, Thierry Leblanc, Emmanuel Raffoux, Anne Auvrignon, Guy Leverger, Patricia Ribaud, Annie Sulahian, Claude Preudhomme, Francis Derouin and Nicolas Boissel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Benoît Brethon

49 papers receiving 1.3k citations

Hit Papers

Blinatumomab Added to Chemotherapy in Infant Lymphoblasti... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia
    2023 83 citations Inge M. van der Sluis, Paola De Lorenzo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoît Brethon France 20 440 393 342 341 296 54 1.3k
Hélène Schoemans Belgium 18 640 1.5× 259 0.7× 265 0.8× 189 0.6× 160 0.5× 69 1.3k
Francesco Fabbiano Italy 18 552 1.3× 213 0.5× 294 0.9× 428 1.3× 350 1.2× 47 1.6k
Richard Champlin United States 15 870 2.0× 259 0.7× 299 0.9× 197 0.6× 201 0.7× 32 1.5k
Nicola Mordini Italy 23 1.2k 2.6× 292 0.7× 387 1.1× 226 0.7× 247 0.8× 52 1.7k
Robert Chiesa United Kingdom 25 657 1.5× 170 0.4× 307 0.9× 231 0.7× 297 1.0× 61 1.7k
Concetta Micalizzi Italy 22 593 1.3× 152 0.4× 124 0.4× 347 1.0× 331 1.1× 81 1.2k
Rita Beier Germany 17 298 0.7× 168 0.4× 166 0.5× 281 0.8× 248 0.8× 49 1.2k
Kazuko Kudo Japan 30 1.3k 3.0× 503 1.3× 335 1.0× 452 1.3× 307 1.0× 102 2.4k
Pere Barba Spain 24 709 1.6× 160 0.4× 256 0.7× 264 0.8× 173 0.6× 90 1.6k
Megumi Oda Japan 19 430 1.0× 132 0.3× 229 0.7× 400 1.2× 183 0.6× 68 1.0k

Countries citing papers authored by Benoît Brethon

Since Specialization
Citations

This map shows the geographic impact of Benoît Brethon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Brethon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Brethon more than expected).

Fields of papers citing papers by Benoît Brethon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Brethon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Brethon. The network helps show where Benoît Brethon may publish in the future.

Co-authorship network of co-authors of Benoît Brethon

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Brethon. A scholar is included among the top collaborators of Benoît Brethon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Brethon. Benoît Brethon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldwirt, Lauriane, Mathieu Simonin, Marie-Émilie Dourthe, et al.. (2024). Monocentric experience of venetoclax‐based regimen in paediatric refractory and relapsed AML/MDS. British Journal of Haematology. 206(1). 209–214.
2.
Brethon, Benoît, et al.. (2023). Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France. PharmacoEconomics - Open. 7(4). 639–653. 1 indexed citations
3.
Orbach, Daniel, Thomas Hanslik, Benoît Brethon, et al.. (2022). Varicella post-exposure management for pediatric oncology patients. Bulletin du Cancer. 109(3). 287–295. 2 indexed citations
4.
Locatelli, Franco, Gerhard Zugmaier, Noemi Mergen, et al.. (2021). Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood Cancer Journal. 11(2). 28–28. 1 indexed citations
5.
Brethon, Benoît, Élodie Lainey, Aurélie Caye‐Eude, et al.. (2021). Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia. Frontiers in Oncology. 11. 637951–637951. 13 indexed citations
6.
7.
Rabian, Florence, Hélène Boutroux, Marion Strullu, et al.. (2019). Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study. Blood. 134(Supplement_1). 5130–5130.
8.
Bouazza, Naïm, Isabelle Aerts, Birgit Geoerger, et al.. (2018). Parents’ and children’s comprehension and decision in a paediatric early phase oncology trial: a prospective study. Archives of Disease in Childhood. 104(10). 947–952. 8 indexed citations
9.
Petit, Arnaud, Amélie Trinquand, Sylvie Chevret, et al.. (2017). Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood. 131(3). 289–300. 61 indexed citations
10.
Gore, Lia, Franco Locatelli, Gerhard Zugmaier, et al.. (2014). Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 124(21). 3703–3703. 19 indexed citations
11.
Herbrecht, Raoul, Denis Caillot, Catherine Cordonnier, et al.. (2012). Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Journal of Antimicrobial Chemotherapy. 67(11). 2731–2738. 37 indexed citations
12.
13.
Chappuy, Hélène, André Baruchel, G Leverger, et al.. (2010). Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia. Archives of Disease in Childhood. 95(10). 800–804. 43 indexed citations
14.
Leblanc, Thierry, Delphine Chamousset, G. Le Roux, et al.. (2009). Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica. 94(4). 487–495. 63 indexed citations
15.
Brethon, Benoît, Karima Yakouben, Caroline Oudot, et al.. (2008). Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia. British Journal of Haematology. 143(4). 541–547. 31 indexed citations
16.
Bertrand, Yves, Françoise Méchinaud, Benoît Brethon, et al.. (2008). SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) Recommendations for the Management of Tumor Lysis Syndrome (TLS) With Rasburicase: An Observational Survey. Journal of Pediatric Hematology/Oncology. 30(4). 267–271. 12 indexed citations
17.
Boissel, Nicolas, Harmony Leroy, Benoît Brethon, et al.. (2006). Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia. 20(6). 965–970. 256 indexed citations
18.
Kerviler, É. de, C. de Bazelaire, Nicolas Mounier, et al.. (2006). Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. European Radiology. 17(3). 843–849. 52 indexed citations
19.
Brethon, Benoît, Anne Auvrignon, Claire Galambrun, et al.. (2006). Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia. BMC Cancer. 6(1). 172–172. 22 indexed citations
20.
Blasey, Horst, Benoît Brethon, Ruud Hovius, et al.. (2000). Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System. Cytotechnology. 32(3). 199–208. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Schoemans Breakdown of academic impact, for papers by Francesco Fabbiano Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by Nicola Mordini Breakdown of academic impact, for papers by Robert Chiesa Breakdown of academic impact, for papers by Concetta Micalizzi Breakdown of academic impact, for papers by Rita Beier Breakdown of academic impact, for papers by Kazuko Kudo Breakdown of academic impact, for papers by Pere Barba Breakdown of academic impact, for papers by Megumi Oda
Rankless by CCL
2026